Cisplatin [cis-diamminedichloroplatinum (II) ; DDP] is an electrophilic platinum coordinate compound which causes DNA damage by forming platinum-DNA coordination complexes (Zwelling & Kohn, 1980) . It is one of the most effective antineoplastic agents clinically used against human small-cell lung cancer (SCLC) (Aisner, 1988) . However, its clinical efficacy as an antineoplastic agent is curtailed in many cancers owing to inherent or acquired resistance to its cytotoxicity (Loehrer & Einhorn, 1984) . Attempts are currently under way to improve the efficacy of DDP by using non-cytotoxic drugs to defeat cellular defence mechanisms that participate in mediating resistance to DDP (TimmerBosscha et al., 1992) . Cellular defence mechanisms that protect cells from DDP-induced DNA damage (Kelley & Rozencweig, 1989; Perez et al., 1990; Tunmer-Bosscha et al., 1992) can be conceptualised as those that repair DDPinduced DNA damage (Teicher et al., 1987; Masuda et al., 1990) , those that decrease the accumulation of DDP into the cell (Teicher et al., 1987; Andrews et al., 1988; Bungo et al., 1990) or those that increase the capacity of cytoplasmic defence mechanisms which interfere with the ability of electrophilic toxins, such as DDP, to interact with DNA (Meijer et al., 1990 ; Kasahara et al., 1991; Muller et al., 1991) . Glutathione (GSH), the chief intracellular nucleophile, functions as a scavenger of electrophilic toxins, and its cellular concentrations have been shown to be increased in some DDP-resistant cell lines (Batist et al., 1986; Meijer et al., 1990; Mistry et al., 1991) . Glutathione S-transferases (GSTs) are multifunctional cellular enzymes which can detoxify electrophiles by conjugating them with GSH (Jakoby, 1978) . I[creased GST activity has been linked with DDP resistance (Teicher et al., 1987; Saburi et al., 1989; Miyazaki et al., 1990; Puchalskci & Fahl, 1990; Sharma et al., 1993) . Because GSTs are susceptible to inhibition by a number of noncytotoxic drugs (van Bladeren & van Ommen, 1991) , they are an attractive target for attempts to enhance DDP efficacy using non-cytotoxic inhibitors, such as ethacrynic acid (a non-cytotoxic diuretic drug). Ethacrynic acid has been shown to enhance the cytotoxic effects of certain alkylating agents (Tew et al., 1988) . However, the GST-x isoenzyme, which has been linked with malignant transformation and with resistance to alkylating agents (Tsuchida & Sato, 1992) , has been suggested to decrease the efficacy of ethacrynic acid in enhancing alkylating agent cytotoxicity (Kuzmich et al., 1992) . Furthermore, ethacrynic acid has been found not to enhance the cytotoxicity of DDP towards resistant malignant cell lines (Plumb et al., 1990) .
During studies aimed at finding alternative non-cytotoxic GST inhibitors, we have found that sulphasalazine (SS), a drug commonly used for the treatment of inflammatory bowel disorders, is an effective inhibitor of GSTs including GST-x (Ahmad et al., 1992) . We have also studied electrophile defence mechanisms, including GSH levels, and activities of enzymes which participate in detoxification of electrophilic toxins, including GSTs, glutathione peroxidase (GPx), glutathione reductase (GR) and glucose-6phosphate dehydrogenase (G6PD), and have found that among these defence mechanisms GST activity correlated best with degree of DDP resistance in these cell lines (Sharma et al., 1993) . The present studies were designed to test the role of GSTs in mediating DDP resistance in two human SCLC cell lines, NCI H-69 and H-2496, in which GST activities parallel DDP resistance, by studying the effect of SS on their GSTs and sensitivity to DDP. The inhibitory effects of SS of GST activity were studied using GSTs purified from these cell lines. A spectrophotometric cytotoxicity assay (Carmichael et al., 1987; Twentyman & Luscombe, 1987) which utilises 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MMT) was used in conjunction with isobologram analysis (Steel & Peckham, 1979) to determine whether SS is able to enhance the cytotoxicity of DDP in a synergistic manner. The major GST isoenzyme in both cell lines was found to be GST-x. SS was found to be a competitive inhibitor of GST-x at concentrations which can be achieved in human serum with its conventional doses (Das & Dubin, 1976) . SS was found to enhance the cytotoxicity of DDP in a synergistic manner in both cell lines, but the degree of synergy was considerably greater towards the H-69 cell line, which was relatively more resistant to DDP and which had a higher GST-x content than the H-2496 cell line. These results support the results of our previous studies (Sharma et al., 1993) which have implicated GST-: as a significnt determinant of DDP resistance and suggest that SS could be clinically used to enhance the anti-tumour efficacy of DDP in malignant cells overexpressing GST-w.
Materiak and methods

Reagents and chemicals
Reagents including SS and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), 1-chloro-2,4-dinitrobenzene (CDNB), 5,5'-dithiobis-2-nitrobenzoic acid (DTNB), dimethylsulphoxide (DMSO), diethylpyrocarbonate, formamide, guanidinium thiocynate and other reagents were purchased from Sigma (St Louis, MO, USA). A random primed labelling kit was purchased from Boehringer-Mannheim (Indianapolis, IN, USA). RadiolabeLled [4- 32P]dCTP (specific activity 6 x 1(9 c.p.m. jig ') was purchased from DuPont NEN Products (Billerica, MA, USA). Zetabind nylon membrane was purchased from Cuno Laboratory (Meridien, CT, USA). DDP was obtained from Bristol Laboratories (Evansville, IN, USA). Fetal bovine serum (FBS) was purchased from Intergen Company (Purchase, NY, USA). Cell culture supplies including RPMI-1640 medium, penicillin-streptomycin (P/S) solution and Dulbecco's phosphate-buffered saline (PBS) were purchased from Gibco Laboratories (Grand Island, NY, USA).
Culture conditions
Two human SCLC cell lines, NCI H-69 and NCI H-2496, were generous gifts from H. Oie at the National Cancer Institute, Baltimore, MD, USA. These SCLC cell lines, which had never been exposed to chemotherapeutic drugs in vitro, grew in suspension cultures in RPMI-1640 medium containing 10% FBS and 1% P/S at 37C in a 5% carbon dioxide atmosphere. Cells were maintained in the log phase of growth by diluting them 1:3 with medium every 2-3 days.
Non-protein sulphydryl content of cell lines Cells growing in log phase were washed with PBS and homogenate prepared by sonication in 10 mm potassium phosphate buffer, pH 7.0. Non-protein sulphydryl (NPSH) content in the acid-soluble fraction of the homogenate was determined spectrophotometrically using DTNB (Beutler et al., 1963) .
GST activity, purification, Western blot analysis and kinetics of inhibition by sulphasalazine GST activity towards CDNB was determined (Habig et al., 1974) on 28,000 g supernatants of the homogenate prepared as described above. One unit of GST activity was defined as I ymol of dinitrophenyl-S-glutathione (Dnp-SG, c0 = 9.6 mM ' cm-') formed per minute at 25C. GSTs were purified from cell homogenate of both cell lines using GSH affinity chromatography as used by us previously (Sharma et al., 1993) . Western blot analysis on the purified GSTs was performed (Towbin et al., 1979) Isobologram analysis Isobolograms and envelopes of additivity were constructed according to the previously described method (Steel & Peckham, 1979 (Das & Dubin, 1976) and suggest that any effect of SS on DDP sensitivity is not caused by SS-induced changes in NPSH. Western blot analysis of purified GSTs revealed the presence of only the GST-x isoenzyme in these cell lines (Figure 1) . The results of Northern blot analysis revealed that only GST-c was present in both cell lines, and GST-a or -j RNA was not detected (figures not presented). These results were consistent with previous studies on the composition of GST isoenzymes in human SCLC cell lines (Miyazaki et al., 1990) . The average GST activity, determined in homogenates of the H-69 and H-2496 cell lines in three separate experiments (317 ± 7 vs 9 ± 1 mU mg-' protein respectively), indicated that the H-69 cell line contained 34-fold higher GST activity than the H-2496 cell line (Sharma et al., 1993) . SS inhibited GSTs of both cell lines with 50% inhibition of activity towards CDNB as seen at 10 and 12 pM for the H-69 and H-2496 cell lines respectively (Figure 2 ). SS was found to be a competitive inhibitor of the GSTs isolated from both cell lines,
with KX values of 6.5 and 7.9 9AM for the H-69 and H-2496 cell lines respectively. An MTT cytotoxicity assay was used to determine the sensitivity of the SCLC cell lines to DDP and sulphasalazine alone and in combination. This assay is based on the optical measurement of a formazan dye which is cleaved from MTT by mitochondrial dehydrogenase of actively respinng mitochondria and has been shown to correlate with results of colony-forming cytotoxicity assays in SCLC cell lines (Carmichael et al., 1987) . The calibration curve of the MTT cytotoxicity assay revealed that absorbances at 560 nm were linear in the range 0.05-1.0 with respect to cell number determined by counting disaggregated cells in a haemocytometer (data not presented). Using this assay, the H-69 cell line was found to be approximately 6-fold more resistant 3a) and SS alone (Figure 3b ) are presented. These survival curves were linear with respect to DDP concentrations, but non-linear with respect to SS concentrations, for both cell lines. On the basis of these results, the use of envelopes of additivity became necessary for the analysis of synergy in isobolograms rather than the theoretical isotoxic dose line, which represented simple additivity of cytotoxicity between the two drugs. Isobolograms showing the theoretical envelopes of additivity and the actual isotoxic dose curves for combinations of SS and DDP are shown for the H-69 ( Figure 4a ) and H-2496 (Figure 4b) 1992), future studies on the effect of suiphasalazine on protein kinase C activty may be helpful in delineating an additional mechanism for the observed nt of DDP cytotoxcity by SS.
Our studies suggest that SS should be added to the long list of agents which can enhance DDP cytotoxicity (TimmerBosscha et al., 1992) . The marked degre of enhancement of DDP toxicity in the H-69 cell line at the lower concentrations of SS is interesting. Based on SS pharmacokinetics in humans, concentrations of SS up to 25 pM can be achieved in human plasma at relatively non-toxic doses of SS (Das & Dubin, 1976) . Furthermore, animal pharmacokinetic studie of SS show that its concentrations in lung and connective tissues are significntly higher Cm the range of 0.5 mM) than in serum, and they can persist for prolonged periods after bolus doses of SS (Hanngren et al., 1%3 
